Lexicon Pharmaceuticals ( LXRX +15.4% ) moves up today on no company-specific news. The company earned fast track status earlier this month from the FDA for its LX1033 drug candidate, an orally delivered small molecule medication for irritable bowel syndrome with diarrhea. Post your comment! Lexicon Pharmaceuticals ( LXRX ) +12.5% premarket after revealing positive top-line results from a midstage study for telotristat etiprate, its investigational new drug to treat carcinoid syndrome. The drug currently has fast track status and orphan drug designation from the FDA, and orphan drug ... Shares of Lexicon Pharmaceuticals ( LXRX ) finished -4% today, despite its earlier announcement that that favorable data from Phase 2b clinical trials of its diabetes drug LX4211 was being presented today at the American Heart Association Scientific Sessions Conference in Los Angeles. According to ... Thank you for holding. Welcome to the Lexicon Pharmaceuticals' First Quarter 2013 Conference Call. At this time, all participants are in listen-only mode. There will be a question-and-answer session to follow. Please be advised that this call is being recorded at Lexicon's request. Welcome to the Lexicon Pharmaceuticals Second Quarter 2011 Conference Call. At this time all participants are in a listen-only mode. There will be a question-and-answer session to follow. Please be advised that this call is being taped at Lexicon s request. Lexicon Pharmaceuticals, Inc. ( LXRX ) Q1 2013 Earnings Call May 10, 2013, 11:00 am ET Executives Alex Abuin - VP, Alliance Management & Corporate Communications Arthur Sands - President & CEO Pablo Lapuerta - SVP, Clinical Development & Chief Medical Officer Brian Zambrowicz - EVP & Chief ... Lexicon Pharmaceuticals, Inc. ( LXRX ) Q4 2012 Earnings Call February 21, 2013 11:00 AM ET Executives Alex Abuin – VP, Communications Arthur Sands – President and CEO Brian Zambrowicz – EVP and Chief Scientific Officer Pablo Lapuerta – SVP and Chief Medical Officer Jeff Wade – EVP, Corporate ... Lexicon Pharmaceuticals, Inc. ( LXRX ) 31st Annual J.P. Morgan Healthcare Conference Call January 9, 2013 12:30 ET Executives Brian Zambrowicz - Executive Vice President and Chief Scientific Officer Analysts Matt Lowe - J.P. Morgan Presentation Matt Lowe - J.P. Morgan Welcome everybody. My name is ... Lexicon Pharmaceuticals, Inc. ( LXRX ) Special Call June 25, 2012 10:00 a.m. ET Executives Wade Walke - Senior Director, Communications and Investor Relations Arthur Sands - President and Chief Executive Officer Brian Zambrowicz - Executive Vice President and Chief Scientific Officer Pablo Lapuerta ... Lexicon Pharmaceuticals, Inc. ( LXRX ) Q3 2012 Earnings Call November 06, 2012, 11:00 am ET Executives Alex Abuin - VP, Alliance Management & Corporate Communications Arthur Sands - President & CEO Pablo Lapuerta - SVP, Clinical Development & Chief Medical Officer Brian Zambrowicz - EVP & Chief ...